Published in Proc Natl Acad Sci U S A on October 01, 1989
The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc Natl Acad Sci U S A (1991) 4.66
Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev (2006) 4.13
HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J (1990) 3.92
Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J Virol (1992) 2.93
Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus. Proc Natl Acad Sci U S A (1990) 2.92
Mining microarray expression data by literature profiling. Genome Biol (2002) 2.86
Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro. Proc Natl Acad Sci U S A (1990) 2.32
In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J Virol (1993) 2.15
Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J (1995) 2.14
TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes. EMBO J (1990) 2.00
Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen. Mol Cell Biol (1993) 1.98
Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated trans activation in rodent cells. J Virol (1990) 1.80
Direct interactions between autoantigen La and human immunodeficiency virus leader RNA. J Virol (1994) 1.70
Efficient trans-activation by the HIV-2 Tat protein requires a duplicated TAR RNA structure. Nucleic Acids Res (1990) 1.67
Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs. Mol Cell Biol (1993) 1.59
Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1990) 1.52
Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein. J Virol (1991) 1.45
Detailed mutational analysis of TAR RNA: critical spacing between the bulge and loop recognition domains. Nucleic Acids Res (1991) 1.44
Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure. J Virol (1992) 1.43
Tat-dependent adenosine-to-inosine modification of wild-type transactivation response RNA. Proc Natl Acad Sci U S A (1991) 1.35
Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation. J Virol (1991) 1.34
The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA. Proc Natl Acad Sci U S A (1991) 1.32
Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C. EMBO J (1990) 1.29
Mutational analysis of the equine infectious anemia virus Tat-responsive element. J Virol (1991) 1.28
Heterologous basic domain substitutions in the HIV-1 Tat protein reveal an arginine-rich motif required for transactivation. EMBO J (1991) 1.24
Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1. J Virol (1994) 1.20
Genetic regulation of human immunodeficiency virus. Microbiol Rev (1991) 1.18
Negative regulation of human immune deficiency virus replication in monocytes. Distinctions between restricted and latent expression in THP-1 cells. J Exp Med (1990) 1.18
The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes. Proc Natl Acad Sci U S A (1993) 1.16
Regulation of eukaryotic gene expression by transcriptional attenuation. Mol Biol Cell (1993) 1.15
The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J Virol (1994) 1.09
Unusual structure of the human immunodeficiency virus type 1 trans-activation response element. J Virol (1992) 1.07
Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides. J Virol (1994) 1.00
TAR loop-dependent human immunodeficiency virus trans activation requires factors encoded on human chromosome 12. J Virol (1993) 1.00
Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1. Retrovirology (2011) 0.99
Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335. Antimicrob Agents Chemother (1992) 0.96
A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. J Virol (1995) 0.94
Induction of RNA-binding proteins in mammalian cells by DNA-damaging agents. Proc Natl Acad Sci U S A (1994) 0.94
Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator. J Virol (1995) 0.90
Human immunodeficiency virus type 1 Tat-mediated trans activation correlates with the phosphorylation state of a cellular TAR RNA stem-binding factor. J Virol (1992) 0.90
Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin. Nucleic Acids Res (1997) 0.89
Transactivation of heterologous promoters by HIV-1 tat. Nucleic Acids Res (1991) 0.85
Down modulation of HIV-1 gene expression using a procaryotic RNA-binding protein. Nucleic Acids Res (1990) 0.84
A human chromosome 12-associated 83-kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA. J Virol (1995) 0.78
Binding by TRBP-dsRBD2 Does Not Induce Bending of Double-Stranded RNA. Biophys J (2016) 0.75
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res (1984) 86.56
Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell (1986) 20.08
An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (1987) 19.23
A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell (1985) 16.46
The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell (1983) 15.09
HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell (1986) 12.74
Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science (1986) 12.58
The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell (1985) 11.28
Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell (1987) 11.15
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science (1988) 11.05
Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell (1986) 10.71
Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature (1988) 10.15
Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science (1986) 8.01
Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc Natl Acad Sci U S A (1986) 8.00
HIV-1 tat trans-activation requires the loop sequence within tar. Nature (1988) 6.87
Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc Natl Acad Sci U S A (1986) 6.57
Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5' untranslated region of ferritin heavy- and light-subunit mRNAs. Proc Natl Acad Sci U S A (1988) 5.93
Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III. Nature (1986) 5.24
Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. Science (1987) 5.22
Expression and characterization of the trans-activator of HTLV-III/LAV virus. Science (1986) 5.15
Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events. Proc Natl Acad Sci U S A (1987) 4.91
Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci U S A (1986) 4.89
Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science (1988) 4.63
Purification and properties of Drosophila heat shock activator protein. Science (1987) 4.60
Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus. EMBO J (1987) 4.14
A trans-acting factor is responsible for the simian virus 40 enhancer activity in vitro. Nature (1985) 4.01
A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator. Mol Cell Biol (1988) 3.74
Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat. J Virol (1988) 3.69
Multiple tandemly repeated binding sites for cellular nuclear factor 1 that surround the major immediate-early promoters of simian and human cytomegalovirus. J Virol (1987) 3.68
Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters. Genes Dev (1988) 3.51
Human immunodeficiency virus long terminal repeat responds to T-cell activation signals. Proc Natl Acad Sci U S A (1987) 3.47
A 64 kd nuclear protein binds to RNA segments that include the AAUAAA polyadenylation motif. Cell (1988) 3.44
Duplications of a mutated simian virus 40 enhancer restore its activity. Nature (1985) 2.75
Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1. EMBO J (1988) 2.74
Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence. J Virol (1988) 2.67
Transcription control by oncogenes. Cell (1985) 2.45
Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel translational control mechanism. Cell (1989) 2.43
Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element. Mol Cell Biol (1987) 2.42
In vitro activation of the HIV-1 enhancer in extracts from cells treated with a phorbol ester tumor promoter. EMBO J (1987) 2.09
Structure of the mouse nucleolin gene. The complete sequence reveals that each RNA binding domain is encoded by two independent exons. J Mol Biol (1988) 1.76
Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA. Nucleic Acids Res (1989) 1.70
Molecular organization of the AIDS retrovirus. Cell (1985) 1.65
Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials. Science (1986) 1.53
Transcriptional activation of homologous viral long terminal repeats by the human immunodeficiency virus type 1 or the human T-cell leukemia virus type I tat proteins occurs in the absence of de novo protein synthesis. Proc Natl Acad Sci U S A (1988) 1.29
Functional characterization of a complex protein-DNA-binding domain located within the human immunodeficiency virus type 1 long terminal repeat leader region. J Virol (1989) 1.19
Synthesis of functional human immunodeficiency virus tat protein in baculovirus as determined by a cell-cell fusion assay. J Virol (1988) 1.06
Human immunodeficiency viral long terminal repeat is functional and can be trans-activated in Escherichia coli. Proc Natl Acad Sci U S A (1989) 0.86
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol (1986) 37.70
Large-scale analysis of the yeast genome by transposon tagging and gene disruption. Nature (1999) 9.87
Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proc Natl Acad Sci U S A (1985) 8.53
Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J (1995) 6.94
A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem Biophys Res Commun (1980) 6.64
Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med (1986) 6.52
Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci U S A (1989) 6.32
Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell (1989) 6.28
Engineering cell shape and function. Science (1994) 5.95
Structures of ternary complexes of rat DNA polymerase beta, a DNA template-primer, and ddCTP. Science (1994) 5.57
Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ (1997) 4.95
Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science (1991) 4.66
A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci U S A (1994) 4.43
Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell (1998) 4.21
Crystal structure of rat DNA polymerase beta: evidence for a common polymerase mechanism. Science (1994) 4.11
Multiple tandemly repeated binding sites for cellular nuclear factor 1 that surround the major immediate-early promoters of simian and human cytomegalovirus. J Virol (1987) 3.68
lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cells. Cell (1987) 3.33
HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J (1999) 3.10
Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat. J Virol (1987) 3.03
A strain-driven morphotropic phase boundary in BiFeO3. Science (2009) 2.95
Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J Virol (1992) 2.93
The canals of Hering and hepatic stem cells in humans. Hepatology (1999) 2.93
HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry (1998) 2.87
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter. Cell (1990) 2.82
Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J Exp Med (1997) 2.76
Association of B12 deficiency and clinical neuropathy with metformin use in type 2 diabetes patients. J Postgrad Med (2013) 2.75
The cost of treating community-acquired pneumonia. Clin Ther (1998) 2.73
Pneumocystis carinii infection in patients of AIDS in India. J Assoc Physicians India (1993) 2.57
Total synthesis of the gene for an alanine transfer ribonucleic acid from yeast. Nature (1970) 2.51
A geometric snake model for segmentation of medical imagery. IEEE Trans Med Imaging (1997) 2.47
Malaria in India: challenges and opportunities. J Biosci (2008) 2.40
Penile strangulation. Br J Urol (1991) 2.40
Mapping tRNA structure in solution using double-strand-specific ribonuclease V1 from cobra venom. Nucleic Acids Res (1981) 2.40
Anomalous ABO phenotype in a child after an ABO-incompatible liver transplantation. N Engl J Med (1992) 2.36
Motor vehicle crashes in dementia of the Alzheimer type. Ann Neurol (1988) 2.36
Genome-wide mutant collections: toolboxes for functional genomics. Curr Opin Microbiol (2000) 2.34
Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc Natl Acad Sci U S A (1996) 2.33
Taking precautions with ACE inhibitors. A theoretical risk exists in patients with unilateral renal artery stenosis. BMJ (1998) 2.32
Comparison of in house polymerase chain reaction with conventional techniques for the detection of Mycobacterium tuberculosis DNA in granulomatous lymphadenopathy. J Clin Pathol (2000) 2.32
Seed-specific over-expression of an Arabidopsis cDNA encoding a diacylglycerol acyltransferase enhances seed oil content and seed weight. Plant Physiol (2001) 2.31
Mycotic aneurysm of left anterior descending artery after sirolimus-eluting stent implantation: a case report. Catheter Cardiovasc Interv (2005) 2.31
The Arabidopsis thaliana TAG1 mutant has a mutation in a diacylglycerol acyltransferase gene. Plant J (1999) 2.30
Randomized trial of intraoperative mitomycin C in surgery for pterygium. Am J Ophthalmol (1998) 2.29
Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J Biol Chem (1998) 2.26
Prevalence and predictors of rhabdomyolysis in patients with hypophosphatemia. Am J Med (1992) 2.24
The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J Biol Chem (2001) 2.23
Fraud in biomedical science. Natl Med J India (1993) 2.23
Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A (2000) 2.23
Energetics of quasiequivalence: computational analysis of protein-protein interactions in icosahedral viruses. Biophys J (1998) 2.22
Mid-arm and chest circumferences at birth as predictors of low birth weight and neonatal mortality in the community. Br Med J (Clin Res Ed) (1985) 2.20
Characterization of messenger ribonucleoprotein and messenger RNA from KB cells. Proc Natl Acad Sci U S A (1972) 2.20
Identification of double-stranded RNA-binding domains in the interferon-induced double-stranded RNA-activated p68 kinase. Proc Natl Acad Sci U S A (1992) 2.20
Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J (1997) 2.16
Early versus delayed laparoscopic cholecystectomy for acute cholecystitis: a prospective randomized trial. Surg Endosc (2004) 2.12
Treatment practices in pulmonary tuberculosis by private sector physicians of Meerut, Uttar Pradesh. Indian J Chest Dis Allied Sci (2012) 2.11
Analysis of the Escherichia coli glycogen gene cluster suggests that catabolic enzymes are encoded among the biosynthetic genes. Gene (1988) 2.10
Purification and domain structure of core hnRNP proteins A1 and A2 and their relationship to single-stranded DNA-binding proteins. J Biol Chem (1986) 2.09
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat Med (1999) 2.07
Ty1-copia group retrotransposons are ubiquitous and heterogeneous in higher plants. Nucleic Acids Res (1992) 2.05
Community based retrospective study of sex in infant mortality in India. BMJ (2003) 2.05
Specific amplification of Aspergillus fumigatus DNA by polymerase chain reaction. Mol Cell Probes (1993) 2.05
Genetic distribution of Bare-1-like retrotransposable elements in the barley genome revealed by sequence-specific amplification polymorphisms (S-SAP). Mol Gen Genet (1997) 2.05
Meconium aspiration syndrome: recent concepts. Indian Pediatr (1993) 2.01
Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J Biol Chem (1997) 2.01
Recovery and identification of West Nile virus from a hawk in winter. J Clin Microbiol (2000) 2.01
Comparison of proteins bound to heterogeneous nuclear RNA and messenger RNA in HeLa cells. J Mol Biol (1975) 2.00
Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J Biol Chem (1997) 1.99
Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis-associated septic shock: a retrospective cohort study. Aliment Pharmacol Ther (2015) 1.99
Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen. Mol Cell Biol (1993) 1.98
Promoter sequences of the human transforming growth factor-beta 1 gene responsive to transforming growth factor-beta 1 autoinduction. J Biol Chem (1989) 1.97
Corneal graft rejection. Surv Ophthalmol (2007) 1.96
Ribosome formation is blocked by camptothecin, a reversible inhibitor of RNA synthesis. Proc Natl Acad Sci U S A (1971) 1.96
The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes. Virology (1989) 1.93
A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions. Mol Cell Biol (1998) 1.93
Total synthesis of the structural gene for the precursor of a tyrosine suppressor transfer RNA from Escherichia coli. 1. General introduction. J Biol Chem (1976) 1.91
Routine radio-imaging in filarial chyluria--is it necessary in developing countries? Br J Urol (1992) 1.91
Studies on polynucleotides. 103. Total synthesis of the structural gene for an alanine transfer ribonucleic acid from yeast. J Mol Biol (1972) 1.90
Immunodiagnosis of aspergillosis. Clin Microbiol Rev (1991) 1.90
Management of posterior capsule tears. Surv Ophthalmol (2001) 1.85
Localization of the coding region for an Epstein-Barr virus early antigen and inducible expression of this 60-kilodalton nuclear protein in transfected fibroblast cell lines. J Virol (1985) 1.85
Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides. Biochem J (2000) 1.84
Host defence mechanisms against dengue virus infection of mice. J Gen Virol (1978) 1.83
Role of adapter function in oncoprotein-mediated activation of NF-kappaB. Human T-cell leukemia virus type I Tax interacts directly with IkappaB kinase gamma. J Biol Chem (1999) 1.82
Extreme heterogeneity of Ty1-copia group retrotransposons in plants. Mol Gen Genet (1992) 1.81
Congenital pouch colon in females. Pediatr Surg Int (1999) 1.81
The embryology and management of congenital pouch colon associated with anorectal agenesis. J Pediatr Surg (1994) 1.80
Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J (1994) 1.78
Mutational analysis of human T-cell leukemia virus type I Tax: regions necessary for function determined with 47 mutant proteins. J Virol (1992) 1.77
Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. J Biol Chem (1999) 1.77
Activation of the NF-kappaB pathway by caspase 8 and its homologs. Oncogene (2000) 1.76
Biosynthesis of bacterial glycogen. Primary structure of Escherichia coli ADP-glucose:alpha-1,4-glucan, 4-glucosyltransferase as deduced from the nucleotide sequence of the glgA gene. J Biol Chem (1986) 1.76
Gastric varices: profile, classification, and management. Am J Gastroenterol (1989) 1.75
All that seems well is not always well--intermittently malfunctioning flexometallic tracheal tubes. Br J Anaesth (2004) 1.75
Identification and characterization of large-effect quantitative trait loci for grain yield under lowland drought stress in rice using bulk-segregant analysis. Theor Appl Genet (2009) 1.75
Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease. Int J Biochem Cell Biol (2004) 1.74